UTHR Aug 2024 350.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

5.04

-1.57

(-23.75%)

At close: 11:58AM EDT

Loading interactive chart…

FX Empire
Big Money Elevating United Therapeutics
The medical devices and novel treatments United Therapeutics Corporation (UTHR) develops to treat pulmonary arterial hypertension (PAH) and other ailments are attracting substantial Big Money investment.
Zacks
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Business Wire
United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., June 27, 2024--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced the addition of former Minnesota Commissioner of Health Jan Malcolm to its Board of Directors. Ms. Malcolm was elected by the company’s shareholders at its annual meeting held on June 26, 2024.